Yazigi 2012.
Study characteristics | ||
Methods | Randomised, double‐blind, placebo control | |
Participants | N = 60, about 52% women | |
Interventions | Pre‐incisional ketamine 0.1 mg/kg bolus IV + 0.05 mg/kg/h infusion IV during surgery and for 72 h postoperatively | |
Outcomes | Pain intensity (VAS) reported every 6 h for 3 days postoperatively. Cumulative analgesic requirement reported at 72 h. AEs | |
Surgery type | Thoracotomy | |
Group numbers after end of study (treatment/control) | 30/30 | |
Age of patient population (treatment/control) | 57.3 ± 11.9 56.9 ± 12.5 |
|
Notes | No financial support or funding and no conflict of interest | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Random number table |
Allocation concealment (selection bias) | Low risk | Central allocation by the hospital pharmacy (a third party). Study drugs were prepared in identical containers and marked with the name of the study and a consecutive number |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Blinded personnel |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Blinded personnel |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No withdrawals |
Selective reporting (reporting bias) | Low risk | Predefined outcomes reported |
Size | High risk | 30 participants per treatment arm |